GSK N 20, Moscow Oblast

Economic indicators

Net profit (RAS) of GSK N 20 grew over 2023 by 15.78% to 939.00 thousand RUB from 811.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period by 15.43% to 965.00 thousand RUB from 836.00 thousand RUB over 2022.

Net profit (RAS) of GSK N 20 grew over 2022 1.92 times to 811.00 thousand RUB from 423.00 thousand RUB over 2021, the company informed.

Revenue increased in the accounting period 1.93 times to 836.00 thousand RUB from 434.00 thousand RUB over 2021.

Net profit (RAS) of GSK N 20 grew over 2021 by 49.47% to 423.00 thousand RUB from 283.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period 1.51 times to 434.00 thousand RUB from 288.00 thousand RUB over 2020.

Net profit (RAS) of GSK N 20 dropped in 2020 by 6.29% to 283.00 thousand RUB from 302.00 thousand RUB over the same period in 2019, the company informed.

Revenue decreased in the accounting period by 7.69% to 288.00 thousand RUB from 312.00 thousand RUB in 2019.

Net profit (RAS) of GSK N 20 grew over 2018 by 14.46% to 277.00 thousand RUB from 242.00 thousand RUB over 2017, the company informed.

Revenue increased in the accounting period by 3.26% to 285.00 thousand RUB from 276.00 thousand RUB over 2017; sales profit went up by 3.26% to 285.00 thousand RUB from 276.00 thousand RUB.

Net profit (RAS) of GSK N 20 dropped in 2017 by 2.02% to 242.00 thousand RUB from 247.00 thousand RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 8.66% to 276.00 thousand RUB from 254.00 thousand RUB over 2016; sales profit went up by 8.66% to 276.00 thousand RUB from 254.00 thousand RUB.

Net profit (RAS) of GSK N 20 dropped in 2016 by 8.86% to 247.00 thousand RUB from 271.00 thousand RUB over the same period in 2015, the company informed.

Revenue decreased in the accounting period by 15.33% to 254.00 thousand RUB from 300.00 thousand RUB in 2015; cost of goods sold decreased Infinity times to 0.00 thousand RUB from 22.00 thousand RUB; sales profit fell by 8.63% to 254.00 thousand RUB from 278.00 thousand RUB.

Net profit (RAS) of GSK N 20 grew over 2014 by 6.88% to 233.00 thousand RUB from 218.00 thousand RUB over 2013, the company informed.

Revenue increased in the accounting period by 6.67% to 240.00 thousand RUB from 225.00 thousand RUB over 2013; sales profit went up by 6.67% to 240.00 thousand RUB from 225.00 thousand RUB.

Companies in the region

• PROFIL'
• OPT
• PROFKOM MEZHRAYONNOY IFNS ROSSII N5 PO RB
• SIBREGIONEKSPORT
• ANTAL-SISTEMS